Jin Li

TL;DR: Apatinib showed improved PFS and OS in heavily pretreated patients with mGC who had experienced treatment failure with two or more chemotherapy regimens, and this trial investigated the safety and efficacy of apatinib, an inhibitor of vascular endothelial growth factor receptor, as a treatment option.

TL;DR: Addition of trastuzumab to chemotherapy is well tolerated and shows improved survival in Chinese patients with advanced gastric or gastro-oesophageal junction cancer, consistent with the results of ToGA whole population trial.

TL;DR: Intravenous injection of 4 mg zoledronic acid can significantly reduce bone pain and bone resorption marker in urine in the Chinese patients with bone metastasis from solid tumor or multiple myeloma, which is tolerable and also comparable to pamidronate in the efficacy and safety.

TL;DR: It is possible to use the anti-HBx monoclonal antibody as a carrier for human HCC targeting therapy and the symptoms of the patients were improved significantly with decreased titre of AFP.

TL;DR: The finding of this study indicates the possibility of using 131I-anti-HBx mAb to target cytostatic drugs to HCC, and specific mAb uptake by tumor was significantly greater than nonspecific IgG on day 7.